Researchers say how quickly a person’s pupil dilates while taking cognitive tests
Alzheimer’s disease (AD) begins to alter and damage the brain years — even decades — before symptoms appear, making early identification of AD risk paramount to slowing its progression.
In a new study published online in the September 9, 2019 issue of the Neurobiology of Aging, scientists at University of California San Diego School of Medicine say that, with further developments, measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
In recent years, researchers investigating the pathology of AD have primarily directed their attention at two causative or contributory factors: the accumulation of protein plaques in the brain called amyloid-beta and tangles of a protein called tau. Both have been linked to damaging and killing neurons, resulting in progressive cognitive dysfunction.
The new study focuses on pupillary responses which are driven by the locus coeruleus (LC), a cluster of neurons in the brainstem involved in regulating arousal and also modulating cognitive function. Tau is the earliest occurring known biomarker for AD; it first appears in the LC; and it is more strongly associated with cognition than amyloid-beta. The study was led by first author William S. Kremen, PhD, and senior author Carol E. Franz, PhD, both professors of psychiatry and co-directors of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine.
The LC drives pupillary response — the changing diameter of the eyes’ pupils — during cognitive tasks. (Pupils get bigger the more difficult the brain task.) In previously published work, the researchers had reported that adults with mild cognitive impairment, often a precursor to AD, displayed greater pupil dilation and cognitive effort than cognitively normal individuals, even if both groups produced equivalent results. Critically, in the latest paper, the scientists link pupillary dilation responses with identified AD risk genes.
“Given the evidence linking pupillary responses, LC and tau and the association between pupillary response and AD polygenic risk scores (an aggregate accounting of factors to determine an individual’s inherited AD risk), these results are proof-of-concept that measuring pupillary response during cognitive tasks could be another screening tool to detect Alzheimer’s before symptom appear,” said Kremen.
Learn more: How the Eyes Might Be Windows to the Risk of Alzheimer’s Disease
The Latest on: Diagnosing Alzheimer’s
[google_news title=”” keyword=”diagnosing Alzheimers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diagnosing Alzheimer’s
- Youth-Onset Diabetes Linked to Higher Alzheimer’s Riskon May 8, 2024 at 1:47 pm
The study discovered blood biomarkers and amyloid protein accumulations typical of AD in individuals diagnosed with diabetes during childhood or adolescence.
- Study seeks to explain why Sephardi Jews more likely to get early-onset Alzheimer’son May 8, 2024 at 12:24 pm
A new study funded by a grant of more than $13 million from the US National Institutes of Health will look into possible genetic reasons why Sephardic Jews are diagnosed with Alzheimer’s disease at ...
- Lauren Miller Rogen’s Mom Died of Alzheimer’s — Here’s How She’s Improving Her Brain Health Every Dayon May 8, 2024 at 11:58 am
Lauren Miller Rogen was just 25 when her mom was diagnosed with early-onset Alzheimer’s. “It was terrible,” Miller Rogen tells SheKnows. Only in her 50s, her mother’s diagnosis was a devastatingly ...
- Study shows potential disparities in early access to Biogen, Eisai's Alzheimer's drugon May 8, 2024 at 2:16 am
A new study points to potential racial and economic disparities in patients’ ability to access Biogen and Eisai's new Alzheimer's disease drug.
- At 54, Terry Kitay was diagnosed with early-onset Alzheimer's disease. This is her daughter's storyon May 7, 2024 at 2:28 pm
Ultimately, at the age of 54, Terry was diagnosed with early-onset Alzheimer's disease — the most common type of dementia. It is progressive and there is no cure. Terry's diagnosis came as a huge ...
- Finding moments of joy: talking to kids about Alzheimer'son May 7, 2024 at 11:46 am
This is a helpful guide to helping a child understand a loved one's Alzheimer's diagnosis. Local experts say the disease doesn't mean the relationship is over, it's just different.
- STAT Virtual Event | Navigating a New Era in Alzheimer’s Treatmenton May 7, 2024 at 7:41 am
A livestream of the event will be embedded below at 1 p.m. ET. t took decades for scientists to come up with treatments that could slow the ...
- Alzheimer's disease may be inherited more often than previously thoughton May 7, 2024 at 12:41 am
Researchers say a subtype of gene known as APOE may be a factor in the inherited form of Alzheimer's and that this kind of the disease may be more common than previously thought ...
- Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’son May 6, 2024 at 9:19 am
People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.
- Jay Leno’s Wife, Mavis, Offers Health Update Months After Alzheimer’s Diagnosison May 1, 2024 at 7:26 am
The update comes after news broke in January that Leno had been granted a conservatorship over his wife of 44 years after she was diagnosed with Alzheimer’s. “I feel great,” Mavis triumphantly told ...
via Bing News